The LXR agonist TO901317 selectively lowers hippocampal Aβ42 and improves memory in the Tg2576 mouse model of Alzheimer's diseaseDavid Riddell, Jan Jacobsen, Cody Lo et al.|Molecular and Cellular Neuroscience|2007Cited by 248
P2‐306: Activation of both LXRα and LXRβ is required for TO901317‐mediated lowering of Aβ42: implications for the development of Alzheimer's therapeuticsDavid Riddell, Peter H. Reinhart, Z. Li et al.|Alzheimer s & Dementia|2008Cited by 0